Detalhe da pesquisa
1.
Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Breast Cancer Res Treat
; 196(1): 185-196, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040641
2.
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
Breast Cancer Res Treat
; 178(2): 459-467, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432367
3.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
; 20(1): 103, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180877
4.
FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics.
Front Oncol
; 13: 1230821, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37546410
5.
Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics.
Cancer Metab
; 11(1): 8, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370158
6.
Physical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmö Diet and Cancer Study.
Cancers (Basel)
; 14(8)2022 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454864
7.
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies.
BMC Cancer
; 11: 341, 2011 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21819622
8.
Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0).
JNCI Cancer Spectr
; 5(1)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33442658
9.
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
Breast Cancer Res Treat
; 121(2): 365-71, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19653096
10.
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
Mod Pathol
; 23(2): 251-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19935641
11.
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer.
NPJ Breast Cancer
; 6: 28, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656317
12.
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups.
Anticancer Res
; 37(12): 6845-6853, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29187464
13.
Changes in Expression of Genes Representing Key Biologic Processes after Neoadjuvant Chemotherapy in Breast Cancer, and Prognostic Implications in Residual Disease.
Clin Cancer Res
; 22(10): 2405-16, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27179111
14.
Early Surrogate Markers of Treatment Activity: Where Are We Now?
J Natl Cancer Inst Monogr
; 2015(51): 24-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063881
15.
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
PLoS One
; 8(12): e81902, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24324728
16.
The combination of Ki67, histological grade and estrogen receptor status identifies a low-risk group among 1,854 chemo-naïve women with N0/N1 primary breast cancer.
Springerplus
; 2(1): 111, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23560250